Finalise Law To Regulate Blood Preservation: HC To Centre

Chandigarh: The Punjab and Haryana high court has urged the Centre to swiftly introduce a legislation to regulate the preservation and disposal of blood — a process governed by executive instructions only and lacking any statutory mechanism in law.

A division bench comprising Chief Justice Sheel Nagu and Justice Anil Kshetarpal has passed the orders while disposing of a suo motu petition on the issue.

“With the hope and expectation that the central govt would act expeditiously in legislating an act to regulate preservation and disposal of blood to avoid any further grievance to the common man, this court draws curtain on the controversy by disposing of the petition with liberty to revisit the court in case any grievance remains un-redressed,” the bench has ordered.

The HC had taken suo motu cognisance of a representation dated March 23, 2017, received from Bathinda Association of NGO’s (Regd), that blood donated by volunteers at donation camps organised in Punjab was being sold to needy patients at exorbitant price. Two separate PILs were also filed on the same cause.

The status reports by various authorities of the central govt as well as Punjab and Haryana indicated that there was no statutory mechanism in law to regulate the process of sale of blood and as such the process was governed by executive instructions in the shape of guidelines issued by the Centre and state govts.

Responding to the issue, it had been informed that the Centre was contemplating formulating statutory provisions to regulate sale and disposal of blood preserved in blood banks. The HC has asked the Centre to finalise the law on the issue expeditiously and consider suggestions given by some of the petitioners if they were found appropriate.

Related Posts

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

The inspection revealed incomplete manufacturing records, poor hygiene, inadequate quality-control systems and the omission of ingredients specified in approved Ayurvedic formulations. The Maharashtra Food and Drug Administration (FDA) on Thursday…

Amneal Pharma completes acquisition of Kashiv BioSciences

Amneal Pharmaceuticals, Inc. announced the completion of its acquisition of Kashiv BioSciences, LLC, creating a fully integrated global biosimilars leader with end-to-end capabilities across research, development, manufacturing and commercialization. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Amneal Pharma completes acquisition of Kashiv BioSciences

Amneal Pharma completes acquisition of Kashiv BioSciences

Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

Delhi High Court Directs Meesho to Remove Alleged Counterfeit Sun Pharma Sunscreen Listings

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis